Current Status and Future Prospects of Genome-Scale Metabolic Modeling to Optimize the Use of Mesenchymal Stem Cells in Regenerative Medicine

Abstract

Mesenchymal stem cells are a promising source for externally grown tissue replacements and patient-specific immunomodulatory treatments. This promise has not yet been fulfilled in part due to production scaling issues and the need to maintain the correct phenotype after re-implantation. One aspect of extracorporeal growth that may be manipulated to optimize cell growth and differentiation is metabolism. The metabolism of MSCs changes during and in response to differentiation and immunomodulatory changes. MSC metabolism may be linked to functional differences but how this occurs and influences MSC function remains unclear. Understanding how MSC metabolism relates to cell function is however important as metabolite availability and environmental circumstances in the body may affect the success of implantation. Genome-scale constraint based metabolic modeling can be used as a tool to fill gaps in knowledge of MSC metabolism, acting as a framework to integrate and understand various data types (e.g., genomic, transcriptomic and metabolomic). These approaches have long been used to optimize the growth and productivity of bacterial production systems and are being increasingly used to provide insights into human health research. Production of tissue for implantation using MSCs requires both optimized production of cell mass and the understanding of the patient and phenotype specific metabolic situation. This review considers the current knowledge of MSC metabolism and how it may be optimized along with the current and future uses of genome scale constraint based metabolic modeling to further this aim.

The Biochemical Profile of Post-Mortem Brain from People Who Suffered from Epilepsy Reveals Novel Insights into the Etiopathogenesis of the Disease

“…Metabolomics, or metabolic profiling, is one of the younger "omics" technologies which comprehensively studies metabolic pathways in biological systems with the focus on metabolites [23,24]. Metabolomics encompasses high-throughput identification and elucidation of the small molecule metabolites that are produced by cells, tissues and microorganisms [25][26][27]. Metabolomics has previously been employed in attempts to diagnose epilepsy, however no single peripheral biomarker panel has demonstrated proven effectiveness [28][29][30][31].…”

Immunomodulating Profile of Dental Mesenchymal Stromal Cells: A Comprehensive Overview

“…Pulp-derived MSCs have been proposed for treating systemic disorders [87] and other types of MSCs, particularly in the area of neuroinflammatory and neurodegenerative diseases [103,104], whereas EVs have been advocated for the control and therapy of autoimmunity [105]. This promising outlook is certainly reinforced by progress in transcriptomics and single-cell analysis of MSCs [106,107], revealing different subsets and mechanisms of action. It is therefore not surprising that MSCs or their exosomes have recently been suggested as a treatment for severe COVID-19 [108][109][110][111].…”

Conditioned Medium of Bone Marrow Mesenchymal Stem Cells Involved in Acute Lung Injury by Regulating Epithelial Sodium Channels via miR-34c

“…Mesenchymal stem cell are being extensively investigated for their potential benefits in tissue engineering and regenerative medicine ( Sigmarsdottir et al, 2020 ). Of note, MSCs have many advantages, such as extensive sources, easy to culture in vitro , and less ethical issues, hence the study of MSCs is more extensive at present.…”